Gold(III) compounds as anticancer agents: Relevance of gold-protein interactions for their mechanism of action.

作者: Angela Casini , Christian Hartinger , Chiara Gabbiani , Enrico Mini , Paul J. Dyson

DOI: 10.1016/J.JINORGBIO.2007.11.003

关键词:

摘要: Gold(III) compounds constitute an emerging class of biologically active substances, special interest as potential anticancer agents. During the past decade a number structurally diverse gold(III) complexes were reported to be acceptably stable under physiological-like conditions and manifest very promising cytotoxic effects against selected human tumour cell lines, making them good candidates anti-tumour drugs. Some representative examples will described in detail. There is considerable understanding precise biochemical mechanisms these novel Based on experimental evidence collected so far we hypothesize that metallodrugs, at variance with classical platinum(II) drugs, produce most cases their growth inhibition through variety "DNA-independent" mechanisms. Notably, strong selenoenzyme thioredoxin reductase associated disregulation mitochondrial functions clearly documented some cases, thus providing solid basis for pronounced proapoptotic effects. These observations led us investigate detail reactions few model proteins order gain molecular-level information possible interaction modes protein targets. Valuable insight formation nature gold-protein adducts was gained ESI MS (electrospray ionization mass spectrometry) spectrophotometric studies appropriate systems it exemplified here by two cytochrome c ubiquitin. The mechanistic relevance gold(III)-induced oxidative damage direct gold coordination sidechains specifically assessed. Perspectives future this topics are briefly outlined.

参考文章(48)
Giordana Marcon, Luigi Messori, Pierluigi Orioli, Maria Agostina Cinellu, Giovanni Minghetti, Reactions of gold(III) complexes with serum albumin FEBS Journal. ,vol. 270, pp. 4655- 4661 ,(2003) , 10.1046/J.1432-1033.2003.03862.X
Glenn F. Rush, Peter F. Smith, Glenn D. Hoke, David W. Alberts, Rosanne M. Snyder, Christopher K. Mirabelli, The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes: II. Triethylphosphine gold chloride-induced alterations in mitochondrial function Toxicology and Applied Pharmacology. ,vol. 90, pp. 391- 400 ,(1987) , 10.1016/0041-008X(87)90131-1
Vito Turk, Boris Turk, Dušan Turk, Lysosomal cysteine proteases: facts and opportunities. The EMBO Journal. ,vol. 20, pp. 4629- 4633 ,(2001) , 10.1093/EMBOJ/20.17.4629
Chi-Ming Che, Raymond Wai-Yin Sun, Wing-Yiu Yu, Chi-Bun Ko, Nianyong Zhu, Hongzhe Sun, Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. Chemical Communications. pp. 1718- 1719 ,(2003) , 10.1039/B303294A
F. Abbate, P. Orioli, B. Bruni, G. Marcon, L. Messori, Crystal structure and solution chemistry of the cytotoxic complex 1,2-dichloro(o-phenanthroline)gold(III) chloride Inorganica Chimica Acta. ,vol. 311, pp. 1- 5 ,(2000) , 10.1016/S0020-1693(00)00299-1
Enrico Weidauer, Yoshiyuki Yasuda, Bichitra K. Biswal, Maia Cherny, Michael N.G. James, Dieter Brömme, Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S Biological Chemistry. ,vol. 388, pp. 331- 336 ,(2007) , 10.1515/BC.2007.037
Dong Wang, Stephen J. Lippard, Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery. ,vol. 4, pp. 307- 320 ,(2005) , 10.1038/NRD1691
Yo Omata, Matt Folan, Melissa Shaw, Regina L. Messer, Petra E. Lockwood, David Hobbs, Serge Bouillaguet, Hidehiko Sano, Jill B. Lewis, John C. Wataha, Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1) Toxicology in Vitro. ,vol. 20, pp. 882- 890 ,(2006) , 10.1016/J.TIV.2006.01.012